EP 2274049 A2 20110119 - TIMING THERAPY EVALUATION TRIALS
Title (en)
TIMING THERAPY EVALUATION TRIALS
Title (de)
TIMING VON UNTERSUCHUNGEN ZUR BEWERTUNG EINER THERAPIE
Title (fr)
ESSAIS D'ÉVALUATION DE THÉRAPIE À SYNCHRONISATION
Publication
Application
Priority
- US 2009040988 W 20090417
- US 4620008 P 20080418
- US 4622508 P 20080418
Abstract (en)
[origin: WO2009129478A2] A characteristic of a washout period following the delivery of therapy to a patient according to a therapy program may be determined based on a physiological parameter of the patient. A washout period includes the period of time during which a carryover effect from the therapy delivery dissipates. Monitoring a washout period may be useful for timing the delivery of therapy according to different therapy programs during a therapy evaluation period. For example, at least one physiological signal of the patient may be monitored to automatically determine when a washout period has ended, e.g., when stimulation and carryover effects of therapy delivery according to a first therapy program have substantially dissipated, in order to determine when therapy delivery according to a second therapy program can be initiated.
IPC 8 full level
A61N 1/36 (2006.01); A61N 1/372 (2006.01)
CPC (source: EP US)
A61M 5/14276 (2013.01 - EP US); A61N 1/36025 (2013.01 - EP); A61N 1/36082 (2013.01 - EP); G16H 20/30 (2017.12 - EP US); G16H 40/40 (2017.12 - EP US); G16H 40/63 (2017.12 - EP US); A61M 5/1723 (2013.01 - EP); A61M 2005/14208 (2013.01 - EP); A61M 2205/3561 (2013.01 - EP); A61M 2205/3592 (2013.01 - EP); A61M 2210/0693 (2013.01 - EP); A61N 1/37211 (2013.01 - EP)
Citation (search report)
See references of WO 2009129478A2
Designated contracting state (EPC)
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO SE SI SK TR
Designated extension state (EPC)
AL BA RS
DOCDB simple family (publication)
WO 2009129478 A2 20091022; WO 2009129478 A3 20091217; WO 2009129478 A4 20100204; EP 2274049 A2 20110119
DOCDB simple family (application)
US 2009040988 W 20090417; EP 09732617 A 20090417